EMCC European Monitoring Centre on Change



Geographic Location

Country: France
Region: Calvados; Basse-Normandie; Bassin Parisien
Location of affected unit(s): Hérouville-Saint-Clair


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 436

Employment Effects

Announcement Date: 02-02-2011
Planned Job Reductions min: 100
Planned Job Reductions max: 100
Type of Restructuring: Merger/Acquisition
Employment Effect Start: 01-01-2012

Additional Information

On 5 October 2011, unions protested to put pressure on the management of US pharmaceutical group Schering-Plough which had announced, in February, a redundancy plan at their site in Hérouville-Saint-Clair (428 employees).

Some 100 jobs are expected to be cut at the site. However the management decided to freeze the restructuring until 31 December 2011 and, meanwhile, find a company to take over the pharmaceutical activities of the site.

CGT union representative Joël Boyer said management has indicated that due to lack of buyer for the pharmaceutical part of the site, production will be transferred to Germany and the Netherlands. The restructuring plan is a consequence of the process of merging with fellow US pharmaceutical company Merck. When the merger was announced, Merck indicated that 15% of the global workforce of the two groups would be cut.